They made use of a drug, called BSO, that interferes with GSH biosynthesis [2] and they presented evidence suggesting that the block was in morphogenesis
As expected, fewer foci and tumors were seen in the C57BL/6 mice
Most side effects are mild and manageable, but there are rare and more severe risks that should not be overlooked
Standard protocol: 100 to 300 mcg per injection, administered 2 to 3 times daily
They do, however, provide biological evidence that matches the lower rates of cirrhosis, cancer and liver-related death found in the wider group
Notably, PFK158 significantly reduced glucose uptake and lactic acid production, and promoted atherosclerotic plaque stability [34], highlighting its anti-atherosclerosis potential